Korea Investment CORP Increases Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Korea Investment CORP increased its stake in HCA Healthcare by 2.0%, owning approximately 0.08% of the company, valued at $67.27 million.
• HCA Healthcare's recent earnings report showed a better-than-expected EPS of $6.84 for the quarter, beating estimates and reflecting a 6.4% revenue growth year-over-year.
• The company announced a quarterly dividend of $0.72 per share, representing an annualized dividend yield of 0.7% and a payout ratio of 12.11%.

Korea Investment CORP boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 194,677 shares of the company's stock after purchasing an additional 3,752 shares during the quarter. Korea Investment CORP owned about 0.08% of HCA Healthcare worth $67,271,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Cheviot Value Management LLC purchased a new position in HCA Healthcare during the 1st quarter worth $26,000. Atwood & Palmer Inc. purchased a new position in HCA Healthcare during the 1st quarter worth $28,000. Bartlett & CO. Wealth Management LLC boosted its holdings in HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after acquiring an additional 80 shares during the last quarter. ORG Partners LLC boosted its holdings in HCA Healthcare by 344.0% during the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after acquiring an additional 86 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. boosted its holdings in HCA Healthcare by 75.8% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after acquiring an additional 50 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of research analyst reports. Bank of America downgraded shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price target on the stock. in a report on Wednesday, July 16th. Morgan Stanley cut their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a report on Monday, July 28th. Barclays cut their price target on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a report on Monday, July 28th. Royal Bank Of Canada cut their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a report on Monday, July 28th. Finally, Truist Financial boosted their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a report on Wednesday, July 16th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and a consensus target price of $398.58.

HCA Healthcare Stock Performance

HCA Healthcare stock traded up $0.61 during midday trading on Friday, reaching $404.87. The stock had a trading volume of 1,081,188 shares, compared to its average volume of 1,326,629. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The firm's 50-day moving average price is $373.91 and its 200 day moving average price is $354.23. The firm has a market capitalization of $94.74 billion, a PE ratio of 17.02, a P/E/G ratio of 1.27 and a beta of 1.39. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same period in the previous year, the business posted $5.50 EPS. The firm's quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is presently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.